We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$535M
AUM Growth
+$28M
Cap. Flow
+$20.7M
Cap. Flow %
3.87%
Top 10 Hldgs %
17.17%
Holding
336
New
30
Increased
83
Reduced
125
Closed
34

Top Buys

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$5.63M
2
MYGN icon
Myriad Genetics
MYGN
+$5.27M
3
AMBA icon
Ambarella
AMBA
+$4.33M
4
EVER icon
EverQuote
EVER
+$3.93M
5
AGX icon
Argan
AGX
+$3.72M

Sector Composition

Rank Sector Weight
1 Industrials 28.91%
2 Technology 24.08%
3 Healthcare 20.66%
4 Financials 5.77%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAE icon
251
Haemonetics
HAE
$4.17B
$57.7K 0.01%
697
-96
-12% -$8.45K
DD icon
252
DuPont de Nemours
DD
$19.4B
$57.5K 0.01%
570
-45
-7% -$4.41K
FCX icon
253
Freeport-McMoran
FCX
$95.4B
$56.6K 0.01%
1,165
EEFT icon
254
Euronet Worldwide
EEFT
$2.68B
$56K 0.01%
541
-74
-12% -$8.09K
UPS icon
255
United Parcel Service
UPS
$89.4B
$55.3K 0.01%
404
PPLI
256
People Inc
PPLI
$2.99B
$54.8K 0.01%
1,426
-198
-12% -$8.18K
CWAN
257
DELISTED
Clearwater Analytics
CWAN
$52K 0.01%
2,809
-390
-12% -$7.04K
DAN icon
258
Dana Inc
DAN
$3.19B
$48.5K 0.01%
3,999
-558
-12% -$7.26K
JNJ icon
259
Johnson & Johnson
JNJ
$631B
$46.6K 0.01%
319
-816
-72% -$121K
BMY icon
260
Bristol-Myers Squibb
BMY
$132B
$46.5K 0.01%
1,120
SPY icon
261
State Street SPDR S&P 500 ETF Trust
SPY
$813B
$44.1K 0.01%
81
MQ icon
262
Marqeta
MQ
$1.65B
$43.4K 0.01%
1,980
-276
-12% -$6.08K
PM icon
263
Philip Morris
PM
$297B
$40.7K 0.01%
402
AWK icon
264
American Water Works
AWK
$27.1B
$39.7K 0.01%
307
-49
-14% -$6.2K
MU icon
265
Micron Technology
MU
$1.08T
$37.4K 0.01%
284
TRIP icon
266
TripAdvisor
TRIP
$1.24B
$37.1K 0.01%
2,081
-291
-12% -$6.31K
EPD icon
267
Enterprise Products Partners
EPD
$82.3B
$36.7K 0.01%
1,266
-924
-42% -$26.5K
FIVE icon
268
Five Below
FIVE
$13.4B
$35.6K 0.01%
327
-47
-13% -$6.51K
MS icon
269
Morgan Stanley
MS
$344B
$35.3K 0.01%
363
PPL
270
PPL Corp
PPL
$26.8B
$34.2K 0.01%
1,238
WEC icon
271
WEC Energy
WEC
$35.8B
$33.7K 0.01%
430
ETN icon
272
Eaton
ETN
$176B
$32K 0.01%
102
-57
-36% -$18.4K
BRK.B icon
273
Berkshire Hathaway Class B
BRK.B
$1.09T
$30.9K 0.01%
76
V icon
274
Visa
V
$671B
$30.7K 0.01%
117
-24
-17% -$6.58K
SRE icon
275
Sempra
SRE
$56.5B
$29.7K 0.01%
390

Similar funds

Essex Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Essex Investment Management held 336 positions worth $535M, up 5.5% from $507M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Essex Investment Management deployed $20.7M of net new capital in Q2 2024, opening 30 new positions and adding to 83 existing holdings. Its largest new stake was Ligand Pharmaceuticals: 70,780 shares worth $5.96M.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Aspen Aerogels, an estimated $2.12M trimmed.

  • Essex Investment Management's largest Q2 2024 buy was Ligand Pharmaceuticals: 70,780 shares worth $5.96M.
  • Essex Investment Management added most to AvePoint in Q2 2024, an estimated $3.22M increase.
  • Essex Investment Management's biggest Q2 2024 reduction was Aspen Aerogels, cutting an estimated $2.12M.
  • Essex Investment Management fully exited Digi International in Q2 2024, selling an estimated $7.01M.
  • Essex Investment Management's ten largest holdings make up 17% of its $535M portfolio in Q2 2024.
  • Essex Investment Management opened 30 new positions and closed 34 in Q2 2024.
  • Essex Investment Management's portfolio value rose 5.5% quarter-over-quarter to $535M.

Based on Essex Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.